Cargando…

Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis

BACKGROUND: Diabetes ketoacidosis (DKA) is a life-threatening complication of type 1 diabetes mellitus (T1DM). Reducing DKA admissions in children with T1DM requires a coordinated, comprehensive management plan. We aimed to decrease DKA admissions, 30-day readmissions, and length of stay (LOS) for D...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilkowitz, Jeniece Trast, Choi, Steven, Rinke, Michael L., Vandervoot, Kathy, Heptulla, Rubina A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health, Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054972/
https://www.ncbi.nlm.nih.gov/pubmed/27749721
http://dx.doi.org/10.1097/QMH.0000000000000109
_version_ 1782458699206361088
author Ilkowitz, Jeniece Trast
Choi, Steven
Rinke, Michael L.
Vandervoot, Kathy
Heptulla, Rubina A.
author_facet Ilkowitz, Jeniece Trast
Choi, Steven
Rinke, Michael L.
Vandervoot, Kathy
Heptulla, Rubina A.
author_sort Ilkowitz, Jeniece Trast
collection PubMed
description BACKGROUND: Diabetes ketoacidosis (DKA) is a life-threatening complication of type 1 diabetes mellitus (T1DM). Reducing DKA admissions in children with T1DM requires a coordinated, comprehensive management plan. We aimed to decrease DKA admissions, 30-day readmissions, and length of stay (LOS) for DKA admissions. METHODS: A multipronged intervention was designed in 2011 to reach all patients: (1) increase insulin pump use and basal-bolus regimen versus sliding scales, (2) transform educational program, (3) increased access to medical providers, and (4) support for patients and families. A before-after study was conducted comparing performance outcomes in years 2007-2010 (preintervention) to 2012-2014 (postintervention) using administrative data and Wilcoxon rank sum and Fischer exact tests. RESULTS: DKA admissions decreased by 44% postintervention (16.7 vs 9.3 per 100 followed patient-years; P = .006), unique patient 30-day readmissions decreased from 20% to 5% postintervention (P = .001), and median LOS significantly decreased postintervention (P < .0001). Although not an original goal of the study, median hemoglobin A1C of a subset of the population transitioned from sliding scale decreased, 10.3% to 8.9% (P < .02). CONCLUSIONS: When clinical and widespread program interventions were used, significant reductions in DKA hospitalizations, 30-day readmissions, and LOS occurred for pediatric T1DM. Continuous performance improvement efforts are needed for improving DKA outcomes.
format Online
Article
Text
id pubmed-5054972
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health, Inc.
record_format MEDLINE/PubMed
spelling pubmed-50549722016-11-01 Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis Ilkowitz, Jeniece Trast Choi, Steven Rinke, Michael L. Vandervoot, Kathy Heptulla, Rubina A. Qual Manag Health Care Quality Improvement BACKGROUND: Diabetes ketoacidosis (DKA) is a life-threatening complication of type 1 diabetes mellitus (T1DM). Reducing DKA admissions in children with T1DM requires a coordinated, comprehensive management plan. We aimed to decrease DKA admissions, 30-day readmissions, and length of stay (LOS) for DKA admissions. METHODS: A multipronged intervention was designed in 2011 to reach all patients: (1) increase insulin pump use and basal-bolus regimen versus sliding scales, (2) transform educational program, (3) increased access to medical providers, and (4) support for patients and families. A before-after study was conducted comparing performance outcomes in years 2007-2010 (preintervention) to 2012-2014 (postintervention) using administrative data and Wilcoxon rank sum and Fischer exact tests. RESULTS: DKA admissions decreased by 44% postintervention (16.7 vs 9.3 per 100 followed patient-years; P = .006), unique patient 30-day readmissions decreased from 20% to 5% postintervention (P = .001), and median LOS significantly decreased postintervention (P < .0001). Although not an original goal of the study, median hemoglobin A1C of a subset of the population transitioned from sliding scale decreased, 10.3% to 8.9% (P < .02). CONCLUSIONS: When clinical and widespread program interventions were used, significant reductions in DKA hospitalizations, 30-day readmissions, and LOS occurred for pediatric T1DM. Continuous performance improvement efforts are needed for improving DKA outcomes. Wolters Kluwer Health, Inc. 2016-10 2016-10-14 /pmc/articles/PMC5054972/ /pubmed/27749721 http://dx.doi.org/10.1097/QMH.0000000000000109 Text en © 2016 Wolters Kluwer Health, Inc. All rights reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Quality Improvement
Ilkowitz, Jeniece Trast
Choi, Steven
Rinke, Michael L.
Vandervoot, Kathy
Heptulla, Rubina A.
Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis
title Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis
title_full Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis
title_fullStr Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis
title_full_unstemmed Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis
title_short Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis
title_sort pediatric type 1 diabetes: reducing admission rates for diabetes ketoacidosis
topic Quality Improvement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054972/
https://www.ncbi.nlm.nih.gov/pubmed/27749721
http://dx.doi.org/10.1097/QMH.0000000000000109
work_keys_str_mv AT ilkowitzjeniecetrast pediatrictype1diabetesreducingadmissionratesfordiabetesketoacidosis
AT choisteven pediatrictype1diabetesreducingadmissionratesfordiabetesketoacidosis
AT rinkemichaell pediatrictype1diabetesreducingadmissionratesfordiabetesketoacidosis
AT vandervootkathy pediatrictype1diabetesreducingadmissionratesfordiabetesketoacidosis
AT heptullarubinaa pediatrictype1diabetesreducingadmissionratesfordiabetesketoacidosis